Haematology - Myeloproliferative Disorders Flashcards

1
Q

What are myeloproliferative disorders?

A

A group of conditions characterise by clonal proliferation of one or more haemopoeitic components
- e.g. increased production of mature cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What myeloproliferative disorders are philadelphia chromosome positive?

A

Chronic myeloid leukaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What myeloproliferative disorders are philadelphia chromosome negative?

A
  • Polycythaemia Vera
  • Myelofibrosis
  • Essential thrombocytosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What mutation is associated with Ph -ve myeloproliferative disorders, and what is this associated with?

A
  • JAK2 mutation
  • Especially polycythaemia Vera (>95%)

A/w:
- Variable increases in reactive polyclonal BM fibrosis
- Terminal acute leukaemia transformation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is polycythaemia?

A

A raised red cell mass, Hb, RCC + packed cell volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are some primary causes of polycythaemia?

A
  • Polycythaemia vera
  • Familial polycythaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some secondary causes of polycythaemia?

A
  • Disease states (e.g. renal cancer)
  • High altitudes
  • Chronic hypoxia (e.g. COPD)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is relative (pseudo) polycythaemia?

A

When the red cell mass is normal but the plasma volume is reduced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some causes of a relative (pseudo) polycythaemia?

A
  • Dehydration
  • Burns
  • Vomiting
  • Diarrhoea
  • Cigarette smoking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is polycythaemia rubra vera?

A
  • A myeloproliferative disorder where erythroid precursors dominate the BM
  • Incidence increases with age
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the point mutations in polycythaemia rubra vera?

A
  • JAK2 (V617F) - 95%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the clinical features of polycythaemia rubra vera?

A
  • Hyperviscosity/hypervolaemia/hypermetabolism
  • Blurred vision, headache
  • Plethoric (red nose), gout, thrombosis + stroke, retinal vein engorgement, erythromelagia
  • Splenomegaly
  • Histamine release = aquagenic pruritis + peptic ulcers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are some investigative findings for a patient with polycythaemia rubra vera?

A
  • Raised Hb, Hct + ?Plts, WCC
  • Low serum EPO
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the treatment for polycythaemia rubra vera?

A
  • Venesection
  • Hydroxycarbamide (maintenance), aspirin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What complications is polycythaemia rubra vera at risk of?

A

Transformation into myelofibrosis/AML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is myelofibrosis?

A

A myeloproliferative disorder where this is fibrosis of the BM or replacement with collagenous tissue

17
Q

What is a primary cause of myelofibrosis?

A

Idiopathic

18
Q

What are some secondary causes of myelofibrosis?

A
  • polycythaemia rubra vera
  • Essential thrombocytosis
  • Leukaemia
19
Q

What are some clinical features of myelofibrosis?

A
  • Usually elderly
  • Pancytopenia-related Sx
  • Extramedullary haematopoeisis (hepatomegaly + MASSIVE SPLENOMEGALY)
  • ?Present with Budd-Chiari Syndrome
20
Q

What are some investigative findings of myelofibrosis?

A

Blood film:
- TEAR DROP POIKILOCYTE (Dacrocyte)
- Leukoerythroblasts (primitive cells)

Bone Marrow:
- Fibrosis
- DRY TAP
- Pancytopenia

Molecular Tests:
- JAK2 mutation (60%)
- MPL mutation
- CALR mutation

21
Q

What is the treatment for myelofibrosis?

A
  • Support with blood products
  • ?splenectomy
  • SCT = Only curative option
  • JAK inhibitor = ruloxitinib, hydroxycarbamide, thalidomide, steroids
22
Q

What is myelofibrosis at risk of transforming into?

A

AML

23
Q

What is essential thrombocythaemia?

A

A myeloproliferative disorder where megakaryocytes dominate the BM

24
Q

What mutations is essential thrombocythaemia associated with?

A
  • JAK2 (50%)
  • MPL mutation
  • CALR
25
Q

What are some clinical features of essential thrombocythaemia?

A
  • Incidental finding in >50%
  • Venous + arterial thrombosis (stroke + MI), gangrene, haemorrhage
  • Erythromelalgia (burning + redness in hands + feet)
  • Splenomegaly
  • dizziness
  • Headahce
  • Visual disturbances
26
Q

What investigative findings are seen in essential thrombocythaemia?

A
  • Plt count >600 X 10^9 (consistent + no other cause)

Blood Film:
- Large plts
- Megakaryocyte fragments

Bone Marrow:
- Increased megakaryocytes (not reactive)

27
Q

What is the treatment for essential thrombocythaemia?

A
  • Aspirin (reduce stroke risk)
  • ANAGRELIDE - reduce transformation of plts from megakaryocytes
  • Hydroxycarbamide